Related Experiment Video
Updated: Aug 12, 2026
08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
[Prognostic factors and radiosensitivity of bladder cancer]
M de las Heras González1, J Salinas Ramos, I de la Fuente
1Area Funcional de Oncología, Hospital Virgen de la Arrixaca, El Palmar, Murcia, España. radioterapia@arrixaca.hura.es
Archivos Espanoles De Urologia
|September 15, 1999
Abstract:
In the near future molecular biology will permit selection of patients with bladder cancer who can benefit more from radiotherapy and chemotherapy. There will also be an increase in the response rate due to the possibility of regulating the genes responsible for cellular radiosensitivity.
